New discoveries in schizophrenia genetics reveal neurobiological pathways: A review of recent findings

European Journal of Medical Genetics

Volumn 58, Issue 12, 2015, Pages 704-714

  Kotlar, Alex V ^a   Mercer, Kristina B ^a   Zwick, Michael E ^c   Mulle, Jennifer G ^b,c  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Copy number variation; GWAS; Psychiatric genetics; Schizophrenia genetics

Indexed keywords

VOLTAGE GATED CALCIUM CHANNEL;

ALLELE; CHROMOSOME 15Q; CHROMOSOME 16P; CHROMOSOME 17P; CHROMOSOME 1Q; CHROMOSOME 22Q; CHROMOSOME 2P; CHROMOSOME 3Q; CHROMOSOME 7Q; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; COPY NUMBER VARIATION; CYTOSKELETON; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; NEUROBIOLOGY; NEXT GENERATION SEQUENCING; PATHOGENESIS; REVIEW; SCHIZOPHRENIA; CHROMOSOME ABERRATION; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HIGH THROUGHPUT SEQUENCING; MENTAL DISEASE; METABOLISM; PROCEDURES; SIGNAL TRANSDUCTION;

CHROMOSOME ABERRATIONS; DNA COPY NUMBER VARIATIONS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MENTAL DISORDERS; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

EID: 84951310422     PISSN: 17697212     EISSN: 18780849     Source Type: Journal    
DOI: 10.1016/j.ejmg.2015.10.008     Document Type: Review

References (138)

1. Diagnostic and Statistical Manual of Mental Disorders 2013, American Psychiatric Association, American Psychiatric Publishing, Arlington. fifth ed.
2. Anaparti V., Ilarraza R., Orihara K., Stelmack G.L., Ojo O.O., Mahood T.H., Unruh H., Halayko A.J., Moqbel R. NMDA receptors mediate contractile responses in human airway smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2015, 308:L1253-L1264.
3. Arias I., Sorlozano A., Villegas E., de Dios Luna J., McKenney K., Cervilla J., Gutierrez B., Gutierrez J. Infectious agents associated with schizophrenia: a meta-analysis. Schizoph. Res. 2012, 136:128-136.
4. Bassett A.S., Marshall C.R., Lionel A.C., Chow E.W., Scherer S.W. Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome. Hum. Mol. Genet. 2008, 17:4045-4053.
5. Bauer E.P., Schafe G.E., LeDoux J.E. NMDA receptors and L-type voltage-gated calcium channels contribute to long-term potentiation and different components of fear memory formation in the lateral amygdala. J. Neurosci. 2002, 22:5239-5249.
6. Bear M.F., Huber K.M., Warren S.T. The mGluR theory of fragile X mental retardation. Trends Neurosci. 2004, 27:370-377.
7. Ben-Shachar S., Lanpher B., German J.R., Qasaymeh M., Potocki L., Nagamani S.C., Franco L.M., Malphrus A., Bottenfield G.W., Spence J.E., Amato S., Rousseau J.A., Moghaddam B., Skinner C., Skinner S.A., Bernes S., Armstrong N., Shinawi M., Stankiewicz P., Patel A., Cheung S.W., Lupski J.R., Beaudet A.L., Sahoo T. Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders. J. Med. Genet. 2009, 46:382-388.
8. Blackwood D., Fordyce A., Walker M., Clair D.S., Porteous D., Muir W. Schizophrenia and affective disorders-cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am. J. Hum. Genet. 2001, 69:428-433.
9. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 361:31-39.
10. Bramham C.R., Alme M.N., Bittins M., Kuipers S.D., Nair R.R., Pai B., Panja D., Schubert M., Soule J., Tiron A., Wibrand K. The Arc of synaptic memory. Exp. Brain Res. 2010, 200:125-140.
11. C.Cross-Disorder Group of the Psychiatric Genomics Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013, 381:1371-1379.
12. C.International Schizophrenia Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008, 455:237-241.
13. C.International Schizophrenia, Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
14. C.Schizophrenia Psychiatric Genome-Wide Association Study Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 2011, 43:969-976.
15. C.Schizophrenia Working Group of the Psychiatric Genomics Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014, 511:421-427.
16. Cannon T.D., Kaprio J., Lonnqvist J., Huttunen M., Koskenvuo M. The genetic epidemiology of schizophrenia in a Finnish twin cohort - a population-based modeling study. Arch. Gen. Psychiatry 1998, 55:67-74.
17. Cannon M., Jones P.B., Murray R.M. Obstetric complications and schizophrenia: historical and meta-analytic review. Am. J. Psychiatry 2002, 159:1080-1092.
18. Cardno A.G., Marshall E.J., Coid B., Macdonald A.M., Ribchester T.R., Davies N.J., Venturi P., Jones L.A., Lewis S.W., Sham P.C., Gottesman I.I., Farmer A.E., McGuffin P., Reveley A.M., Murray R.M. Heritability estimates for psychotic disorders - the Maudsley Twin psychosis series. Arch. Gen. Psychiatry 1999, 56:162-168.
19. Catterall W.A. Voltage-gated calcium channels. Cold Spring Harb. Perspect. Biol. 2011, 3:a003947.
20. Cox D.M., Butler M.G. A clinical case report and literature review of the 3q29 microdeletion syndrome. Clin. Dysmorphol. 2015, 24:89-94.
21. Cox D., Butler M. The 15q11.2 BP1-BP2 microdeletion syndrome: a review. Int. J. Mol. Sci. 2015, 16:4068.
22. Crespi B.J., Crofts H.J. Association testing of copy number variants in schizophrenia and autism spectrum disorders. J. Neurodev. Disord. 2012, 4:15.
23. Dabell M.P., Rosenfeld J.A., Bader P., Escobar L.F., El-Khechen D., Vallee S.E., Dinulos M.B., Curry C., Fisher J., Tervo R., Hannibal M.C., Siefkas K., Wyatt P.R., Hughes L., Smith R., Ellingwood S., Lacassie Y., Stroud T., Farrell S.A., Sanchez-Lara P.A., Randolph L.M., Niyazov D., Stevens C.A., Schoonveld C., Skidmore D., MacKay S., Miles J.H., Moodley M., Huillet A., Neill N.J., Ellison J.W., Ballif B.C., Shaffer L.G. Investigation of NRXN1 deletions: clinical and molecular characterization. Am. J. Med. Genet. A 2013, 161A:717-731.
24. Darnell J.C., Van Driesche S.J., Zhang C., Hung K.Y., Mele A., Fraser C.E., Stone E.F., Chen C., Fak J.J., Chi S.W., Licatalosi D.D., Richter J.D., Darnell R.B. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 2011, 146:247-261.
25. Davies G., Welham J., Chant D., Torrey E.F., McGrath J. A systematic review and meta-analysis of Northern Hemisphere season of birth studies in schizophrenia. Schizophr. Bull. 2003, 29:587-593.
26. Edbauer D., Neilson J.R., Foster K.A., Wang C.F., Seeburg D.P., Batterton M.N., Tada T., Dolan B.M., Sharp P.A., Sheng M. Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron 2010, 65:373-384.
27. Elston R., Campbell M. Schizophrenia: evidence for the major gene hypothesis. Behav. Genet. 1970, 1:3-10.
28. Fatemi S.H., Kneeland R.E., Liesch S.B., Folsom T.D. Fragile X mental retardation protein levels are decreased in major psychiatric disorders. Schizoph. Res. 2010, 124:246-247.
29. Ferreira M.A., O'Donovan M.C., Meng Y.A., Jones I.R., Ruderfer D.M., Jones L., Fan J., Kirov G., Perlis R.H., Green E.K., Smoller J.W., Grozeva D., Stone J., Nikolov I., Chambert K., Hamshere M.L., Nimgaonkar V.L., Moskvina V., Thase M.E., Caesar S., Sachs G.S., Franklin J., Gordon-Smith K., Ardlie K.G., Gabriel S.B., Fraser C., Blumenstiel B., Defelice M., Breen G., Gill M., Morris D.W., Elkin A., Muir W.J., McGhee K.A., Williamson R., MacIntyre D.J., MacLean A.W., St C.D., Robinson M., Van Beck M., Pereira A.C., Kandaswamy R., McQuillin A., Collier D.A., Bass N.J., Young A.H., Lawrence J., Ferrier I.N., Anjorin A., Farmer A., Curtis D., Scolnick E.M., McGuffin P., Daly M.J., Corvin A.P., Holmans P.A., Blackwood D.H., Gurling H.M., Owen M.J., Purcell S.M., Sklar P., Craddock N., C.Wellcome Trust Case Control Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat. Genet. 2008, 40:1056-1058.
30. Ferron L., Nieto-Rostro M., Cassidy J.S., Dolphin A.C. Fragile X mental retardation protein controls synaptic vesicle exocytosis by modulating N-type calcium channel density. Nat. Commun. 2014, 5:3628.
31. Fromer M., Pocklington A.J., Kavanagh D.H., Williams H.J., Dwyer S., Gormley P., Georgieva L., Rees E., Palta P., Ruderfer D.M., Carrera N., Humphreys I., Johnson J.S., Roussos P., Barker D.D., Banks E., Milanova V., Grant S.G., Hannon E., Rose S.A., Chambert K., Mahajan M., Scolnick E.M., Moran J.L., Kirov G., Palotie A., McCarroll S.A., Holmans P., Sklar P., Owen M.J., Purcell S.M., O'Donovan M.C. De novo mutations in schizophrenia implicate synaptic networks. Nature 2014, 506:179-184.
32. Gilman S.R., Iossifov I., Levy D., Ronemus M., Wigler M., Vitkup D. Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 2011, 70:898-907.
33. Girirajan S., Dennis Megan Y., Baker C., Malig M., Coe Bradley P., Campbell Catarina D., Mark K., Vu Tiffany H., Alkan C., Cheng Z., Biesecker Leslie G., Bernier R., Eichler Evan E. Refinement and discovery of new hotspots of copy-number variation associated with Autism Spectrum Disorder. Am. J. Hum. Genet. 2013, 92:221-237.
34. Gottesman I.I., Shields J. A polygenic theory of schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 1967, 58:199.
35. Greer P.L., Hanayama R., Bloodgood B.L., Mardinly A.R., Lipton D.M., Flavell S.W., Kim T.K., Griffith E.C., Waldon Z., Maehr R., Ploegh H.L., Chowdhury S., Worley P.F., Steen J., Greenberg M.E. The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc. Cell 2010, 140:704-716.
36. Grozeva D., Conrad D.F., Barnes C.P., Hurles M., Owen M.J., O'Donovan M.C., Craddock N., Kirov G. Wtccc, independent estimation of the frequency of rare CNVs in the UK population confirms their role in schizophrenia. Schizoph. Res. 2012, 135:1-7.
37. Guha S., Rees E., Darvasi A., Ivanov D., Ikeda M., Bergen S.E., Magnusson P.K., Cormican P., Morris D., Gill M., Cichon S., Rosenfeld J.A., Lee A., Gregersen P.K., Kane J.M., Malhotra A.K., Rietschel M., Nöthen M.M., Degenhardt F., Priebe L., Breuer R., Strohmaier J., Ruderfer D.M., Moran J.L., Chambert K.D., Sanders A.R., Shi J., C.Molecular Genetics of Schizophrenia, C.Wellcome Trust Case Control, Kendler K., Riley B., O'Neill T., Walsh D., Malhotra D., Corvin A., Purcell S., Sklar P., Iwata N., Hultman C.M., Sullivan P.F., Sebat J., McCarthy S., Gejman P.V., Levinson D.F., Owen M.J., O'Donovan M.C., Lencz T., Kirov G. A rare deletion at distal 16p11.2 is implicated in schizophrenia. JAMA Psychiatry (Chicago, Ill.) 2013, 70:253-260.
38. Guilmatre A., Dubourg C., Mosca A.L., Legallic S., Goldenberg A., Drouin-Garraud V., Layet V., Rosier A., Briault S., Bonnet-Brilhault F., Laumonnier F., Odent S., Le Vacon G., Joly-Helas G., David V., Bendavid C., Pinoit J.M., Henry C., Impallomeni C., Germano E., Tortorella G., Di Rosa G., Barthelemy C., Andres C., Faivre L., Frebourg T., Saugier Veber P., Campion D. Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch. Gen. Psychiatry 2009, 66:947-956.
39. Guzowski J.F., Lyford G.L., Stevenson G.D., Houston F.P., McGaugh J.L., Worley P.F., Barnes C.A. Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenance of long-term potentiation and the consolidation of long-term memory. J. Neurosci. 2000, 20:3993-4001.
40. Hahn C.G., Wang H.Y., Cho D.S., Talbot K., Gur R.E., Berrettini W.H., Bakshi K., Kamins J., Borgmann-Winter K.E., Siegel S.J., Gallop R.J., Arnold S.E. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat. Med. 2006, 12:824-828.
41. Hamdan F.F., Gauthier J., Araki Y., Lin D.T., Yoshizawa Y., Higashi K., Park A.R., Spiegelman D., Dobrzeniecka S., Piton A., Tomitori H., Daoud H., Massicotte C., Henrion E., Diallo O., Group S.D., Shekarabi M., Marineau C., Shevell M., Maranda B., Mitchell G., Nadeau A., D'Anjou G., Vanasse M., Srour M., Lafreniere R.G., Drapeau P., Lacaille J.C., Kim E., Lee J.R., Igarashi K., Huganir R.L., Rouleau G.A., Michaud J.L. Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. Am. J. Hum. Genet. 2011, 88:306-316.
42. Hannes F.D., Sharp A.J., Mefford H.C., de Ravel T., Ruivenkamp C.A., Breuning M.H., Fryns J.P., Devriendt K., Van Buggenhout G., Vogels A., Stewart H., Hennekam R.C., Cooper G.M., Regan R., Knight S.J.L., Eichler E.E., Vermeesch J.R. Recurrent reciprocal deletions and duplications of 16p13.11: the deletion is a risk factor for MR/MCA while the duplication may be a rare benign variant. J. Med. Genet. 2009, 46:223-232.
43. Harrison P.J., Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 2005, 10:40-68. image 45.
44. Henquet C., Murray R., Linszen D., van Os J. The environment and schizophrenia: the role of cannabis use. Schizophr. Bull. 2005, 31:608-612.
45. Heston L.L. Psychiatric disorders in foster home reared children of schizophrenic mothers. Br. J. Psychiatry 1966, 112:819-825.
46. Hultman C.M., Sparen P., Takei N., Murray R.M., Cnattingius S. Prenatal and perinatal risk factors for schizophrenia, affective psychosis, and reactive psychosis of early onset: case-control study. BMJ 1999, 318:421-426.
47. Ikeda M., Aleksic B., Kirov G., Kinoshita Y., Yamanouchi Y., Kitajima T., Kawashima K., Okochi T., Kishi T., Zaharieva I., Owen M.J., O'Donovan M.C., Ozaki N., Iwata N. Copy number variation in schizophrenia in the Japanese population. Biol. Psychiatry 2010, 67:283-286.
48. Ingason A., Kirov G., Giegling I., Hansen T., Isles A.R., Jakobsen K.D., Kristinsson K.T., le Roux L., Gustafsson O., Craddock N., Möller H.-J., McQuillin A., Muglia P., Cichon S., Rietschel M., Ophoff R.A., Djurovic S., Andreassen O.A., Pietiläinen O.P.H., Peltonen L., Dempster E., Collier D.A., St Clair D., Rasmussen H.B., Glenthøj B.Y., Kiemeney L.A., Franke B., Tosato S., Bonetto C., Saemundsen E., Hreidarsson S.J., Investigators G., Nöthen M.M., Gurling H., O'Donovan M.C., Owen M.J., Sigurdsson E., Petursson H., Stefansson H., Rujescu D., Stefansson K., Werge T. Maternally derived microduplications at 15q11-q13: Implication of imprinted genes in psychotic illness. Am. J. Psychiatry 2011, 168:408-417.
49. Ingason A., Rujescu D., Cichon S., Sigurdsson E., Sigmundsson T., Pietilainen O.P., Buizer-Voskamp J.E., Strengman E., Francks C., Muglia P., Gylfason A., Gustafsson O., Olason P.I., Steinberg S., Hansen T., Jakobsen K.D., Rasmussen H.B., Giegling I., Moller H.J., Hartmann A., Crombie C., Fraser G., Walker N., Lonnqvist J., Suvisaari J., Tuulio-Henriksson A., Bramon E., Kiemeney L.A., Franke B., Murray R., Vassos E., Toulopoulou T., Muhleisen T.W., Tosato S., Ruggeri M., Djurovic S., Andreassen O.A., Zhang Z., Werge T., Ophoff R.A., Investigators G., Rietschel M., Nothen M.M., Petursson H., Stefansson H., Peltonen L., Collier D., Stefansson K., St Clair D.M. Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol. Psychiatry 2011, 16:17-25.
50. Itsara A., Cooper G.M., Baker C., Girirajan S., Li J., Absher D., Krauss R.M., Myers R.M., Ridker P.M., Chasman D.I., Mefford H., Ying P., Nickerson D.A., Eichler E.E. Population analysis of large copy number variants and hotspots of human genetic disease. Am. J. Hum. Genet. 2009, 84:148-161.
51. Iwata Y., Nakajima S., Suzuki T., Keefe R.S., Plitman E., Chung J.K., Caravaggio F., Mimura M., Graff-Guerrero A., Uchida H. Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials. Mol Psychiatry 2015, 10.1038/mp.2015.68.
52. Javitt D.C., Zukin S.R., Heresco-Levy U., Umbricht D. Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia. Schizophr. Bull. 2012, 38:958-966.
53. Kallmann F.J. The genetics of schizophrenia 1938, J. J. Augustin, Oxford, England.
54. Kallmann F.J. The genetic theory of schizophrenia: an analysis of 691 schizophrenic twin index families. Am. J. Psychiatry 1946, 103:309-322.
55. Kamiya K., Kaneda M., Sugawara T., Mazaki E., Okamura N., Montal M., Makita N., Tanaka M., Fukushima K., Fujiwara T., Inoue Y., Yamakawa K. A nonsense mutation of the sodium channel gene SCN2A in a patient with intractable epilepsy and mental decline. J. Neurosci. 2004, 24:2690-2698.
56. Kelleher R.J., Bear M.F. The autistic neuron: troubled translation?. Cell 2008, 135:401-406.
57. Kendell R.E., Adams W. Unexplained fluctuations in the risk for schizophrenia by month and year of birth. Br. J. Psychiatry 1991, 158:758-763.
58. Kety S.S., Rosenthal D., Wender P.H., Schulsinger F. The types and prevalence of mental illness in the biological and adoptive families of adopted schizophrenics. J. Psychiatric Res. 1968, 6:345-362.
59. Kety S.S., Rosenthal D., Wender P.H., Schulsinger F., Jacobsen B. Mental illness in the biological and adoptive families of adopted individuals who have become schizophrenic. Behav. Genet. 1976, 6:219-225.
60. Kimura H., Tsuboi D., Wang C., Kushima I., Koide T., Ikeda M., Iwayama Y., Toyota T., Yamamoto N., Kunimoto S., Nakamura Y., Yoshimi A., Banno M., Xing J., Takasaki Y., Yoshida M., Aleksic B., Uno Y., Okada T., Iidaka T., Inada T., Suzuki M., Ujike H., Kunugi H., Kato T., Yoshikawa T., Iwata N., Kaibuchi K., Ozaki N. Identification of rare, single-nucleotide mutations in NDE1 and their contributions to schizophrenia susceptibility. Schizophr. Bull. 2015, 41:744-753.
61. Kirov G., Gumus D., Chen W., Norton N., Georgieva L., Sari M., O'Donovan M.C., Erdogan F., Owen M.J., Ropers H.H., Ullmann R. Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum. Mol. Genet. 2008, 17:458-465.
62. Kirov G., Rujescu D., Ingason A., Collier D.A., O'Donovan M.C., Owen M.J. Neurexin 1 (NRXN1) deletions in schizophrenia. Schizophr. Bull. 2009, 35:851-854.
63. Kirov G., Grozeva D., Norton N., Ivanov D., Mantripragada K.K., Holmans P., C.International Schizophrenia, C.Wellcome Trust Case Control, Craddock N., Owen M.J., O'Donovan M.C. Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum. Mol. Genet. 2009, 18:1497-1503.
64. Kirov G., Pocklington A.J., Holmans P., Ivanov D., Ikeda M., Ruderfer D., Moran J., Chambert K., Toncheva D., Georgieva L., Grozeva D., Fjodorova M., Wollerton R., Rees E., Nikolov I., van de Lagemaat L.N., Bayes A., Fernandez E., Olason P.I., Bottcher Y., Komiyama N.H., Collins M.O., Choudhary J., Stefansson K., Stefansson H., Grant S.G., Purcell S., Sklar P., O'Donovan M.C., Owen M.J. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol. Psychiatry 2012, 17:142-153.
65. Krabbendam L., van Os J. Schizophrenia and urbanicity: a major environmental influence-conditional on genetic risk. Schizophr. Bull. 2005, 31:795-799.
66. Kristiansen L.V., Patel S.A., Haroutunian V., Meador-Woodruff J.H. Expression of the NR2B-NMDA receptor subunit and its Tbr-1/CINAP regulatory proteins in postmortem brain suggest altered receptor processing in schizophrenia. Synapse 2010, 64:495-502.
67. Kwon Y.T., Balogh S.A., Davydov I.V., Kashina A.S., Yoon J.K., Xie Y., Gaur A., Hyde L., Denenberg V.H., Varshavsky A. Altered activity, social behavior, and spatial memory in mice lacking the NTAN1p amidase and the asparagine branch of the N-end rule pathway. Mol. Cell Biol. 2000, 20:4135-4148.
68. Lee H.K., Kameyama K., Huganir R.L., Bear M.F. NMDA induces long-term synaptic depression and dephosphorylation of the GluR1 subunit of AMPA receptors in hippocampus. Neuron 1998, 21:1151-1162.
69. Lee K.H., Park J.Y., Kim K. NMDA receptor-mediated calcium influx plays an essential role in myoblast fusion. FEBS Lett. 2004, 578:47-52.
70. Levinson D.F., Duan J., Oh S., Wang K., Sanders A.R., Shi J., Zhang N., Mowry B.J., Olincy A., Amin F., Cloninger C.R., Silverman J.M., Buccola N.G., Byerley W.F., Black D.W., Kendler K.S., Freedman R., Dudbridge F., Pe'er I., Hakonarson H., Bergen S.E., Fanous A.H., Holmans P.A., Gejman P.V. Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am. J. Psychiatry 2011, 168:302-316.
71. Lichtenstein P., Yip B.H., Bjork C., Pawitan Y., Cannon T.D., Sullivan P.F., Hultman C.M. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009, 373:234-239.
72. Luo X., Huang L., Han L., Luo Z., Hu F., Tieu R., Gan L. Systematic prioritization and integrative analysis of copy number variations in schizophrenia reveal key schizophrenia susceptibility genes. Schizophr. Bull. 2014, 40:1285-1299.
73. Lyford G.L., Yamagata K., Kaufmann W.E., Barnes C.A., Sanders L.K., Copeland N.G., Gilbert D.J., Jenkins N.A., Lanahan A.A., Worley P.F. Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron 1995, 14:433-445.
74. Lynch M.A. Long-term potentiation and memory. Physiol. Rev. 2004, 84:87-136.
75. Maillard A.M., Ruef A., Pizzagalli F., Migliavacca E., Hippolyte L., Adaszewski S., Dukart J., Ferrari C., Conus P., Mannik K., Zazhytska M., Siffredi V., Maeder P., Kutalik Z., Kherif F., Hadjikhani N., Beckmann J.S., Reymond A., Draganski B., Jacquemont S., C.p11.2 European The 16p11.2 locus modulates brain structures common to autism, schizophrenia and obesity. Mol. Psychiatry 2015, 20:140-147.
76. Malaspina D., Harlap S., Fennig S., Heiman D., Nahon D., Feldman D., Susser E.S. Advancing paternal age and the risk of schizophrenia. Arch. Gen. Psychiatry 2001, 58:361-367.
77. Malhotra D., Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell 2012, 148:1223-1241.
78. Martin A.K., Robinson G., Reutens D., Mowry B. Copy number deletion burden is associated with cognitive, structural, and resting-state network differences in patients with schizophrenia. Behav. Brain Res. 2014, 272:324-334.
79. McCarthy S.E., Makarov V., Kirov G., Addington A.M., McClellan J., Yoon S., Perkins D.O., Dickel D.E., Kusenda M., Krastoshevsky O., Krause V., Kumar R.A., Grozeva D., Malhotra D., Walsh T., Zackai E.H., Kaplan P., Ganesh J., Krantz I.D., Spinner N.B., Roccanova P., Bhandari A., Pavon K., Lakshmi B., Leotta A., Kendall J., Lee Y.H., Vacic V., Gary S., Iakoucheva L.M., Crow T.J., Christian S.L., Lieberman J.A., Stroup T.S., Lehtimaki T., Puura K., Haldeman-Englert C., Pearl J., Goodell M., Willour V.L., Derosse P., Steele J., Kassem L., Wolff J., Chitkara N., McMahon F.J., Malhotra A.K., Potash J.B., Schulze T.G., Nothen M.M., Cichon S., Rietschel M., Leibenluft E., Kustanovich V., Lajonchere C.M., Sutcliffe J.S., Skuse D., Gill M., Gallagher L., Mendell N.R., C.Wellcome Trust Case Control, Craddock N., Owen M.J., O'Donovan M.C., Shaikh T.H., Susser E., Delisi L.E., Sullivan P.F., Deutsch C.K., Rapoport J., Levy D.L., King M.C., Sebat J. Microduplications of 16p11.2 are associated with schizophrenia. Nat. Genet. 2009, 41:1223-1227.
80. Melhem N., Middleton F., McFadden K., Klei L., Faraone S.V., Vinogradov S., Tiobech J., Yano V., Kuartei S., Roeder K., Byerley W., Devlin B., Myles-Worsley M. Copy number variants for schizophrenia and related psychotic disorders in Oceanic Palau: risk and transmission in extended pedigrees. Biol. Psychiatry 2011, 70:1115-1121.
81. Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H., Burnashev N., Sakmann B., Seeburg P.H. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 1992, 256:1217-1221.
82. Moreno-De-Luca D., Mulle J.G., Kaminsky E.B., Sanders S.J., Myers S.M., Adam M.P., Pakula A.T., Eisenhauer N.J., Uhas K., Weik L., Guy L., Care M.E., Morel C.F., Boni C., Salbert B.A., Chandrareddy A., Demmer L.A., Chow E.W., Surti U., Aradhya S., Pickering D.L., Golden D.M., Sanger W.G., Aston E., Brothman A.R., Gliem T.J., Thorland E.C., Ackley T., Iyer R., Huang S., Barber J.C., Crolla J.A., Warren S.T., Martin C.L., Ledbetter D.H. Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia. Am. J. Hum. Genet. 2010, 87:618-630.
83. Mulle J.G. The 3q29 deletion confers >40-fold increase in risk for schizophrenia. Mol. Psychiatry 2015, 20:1028-1029.
84. Mulle J.G., Dodd A.F., McGrath J.A., Wolyniec P.S., Mitchell A.A., Shetty A.C., Sobreira N.L., Valle D., Rudd M.K., Satten G., Cutler D.J., Pulver A.E., Warren S.T. Microdeletions of 3q29 confer high risk for schizophrenia. Am. J. Hum. Genet. 2010, 87:229-236.
85. Mulle J.G., Pulver A.E., McGrath J.M., Wolyniec P., Dodd A.F., Cutler D.J., Sebat J., Malhotra D., Nestadt G., Conrad D.F., Hurles M., Barnes C.P., Ikeda M., Iwata N., Levinson D.F., Gejman P.V., Sanders A.R., Duan J., Mitchell A.A., Peter I., Sklar P., O'Dushlaine C.T., Grozeva D., O'Donovan M.C., Owen M.J., Hultman C.M., Kähler A.K., Sullivan P.F., Kirov G., Warren S.T. Reciprocal duplication of the Williams-Beuren syndrome deletion on chromosome 7q11.23 is associated with schizophrenia. Biol. Psychiatry 2014, 75:371-377.
86. Ni X., Valente J., Azevedo M.H., Pato M.T., Pato C.N., Kennedy J.L. Connexin 50 gene on human chromosome 1q21 is associated with schizophrenia in matched case-control and family-based studies. J. Med. Genet. 2007, 44:532-536.
87. Niklasson L., Rasmussen P., Oskarsdottir S., Gillberg C. Autism, ADHD, mental retardation and behavior problems in 100 individuals with 22q11 deletion syndrome. Res. Dev. Disabil. 2009, 30:763-773.
88. Noor A., Dupuis L., Mittal K., Lionel A.C., Marshall C.R., Scherer S.W., Stockley T., Vincent J.B., Mendoza-Londono R., Stavropoulos D.J. 15q11.2 duplication encompassing only the UBE3A gene is associated with developmental delay and neuropsychiatric phenotypes. Hum. Mutat. 2015, 36:689-693.
89. O'Donovan M.C., Craddock N., Norton N., Williams H., Peirce T., Moskvina V., Nikolov I., Hamshere M., Carroll L., Georgieva L., Dwyer S., Holmans P., Marchini J.L., Spencer C.C.A., Howie B., Leung H.-T., Hartmann A.M., Moller H.-J., Morris D.W., Shi Y., Feng G., Hoffmann P., Propping P., Vasilescu C., Maier W., Rietschel M., Zammit S., Schumacher J., Quinn E.M., Schulze T.G., Williams N.M., Giegling I., Iwata N., Ikeda M., Darvasi A., Shifman S., He L., Duan J., Sanders A.R., Levinson D.F., Gejman P.V., Cichon S., Nothen M.M., Gill M., Corvin A., Rujescu D., Kirov G., Owen M.J. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat. Genet. 2008, 40:1053-1055.
90. Ogiwara I., Ito K., Sawaishi Y., Osaka H., Mazaki E., Inoue I., Montal M., Hashikawa T., Shike T., Fujiwara T., Inoue Y., Kaneda M., Yamakawa K. De novo mutations of voltage-gated sodium channel alphaII gene SCN2A in intractable epilepsies. Neurology 2009, 73:1046-1053.
91. Park N., Juo S.H., Cheng R., Liu J., Loth J.E., Lilliston B., Nee J., Grunn A., Kanyas K., Lerer B., Endicott J., Gilliam T.C., Baron M. Linkage analysis of psychosis in bipolar pedigrees suggests novel putative loci for bipolar disorder and shared susceptibility with schizophrenia. Mol. Psychiatry 2004, 9:1091-1099.
92. Pei Z., Lang B., Fragoso Y.D., Shearer K.D., Zhao L., McCaffery P.J., Shen S., Ding Y.Q., McCaig C.D., Collinson J.M. The expression and roles of Nde1 and Ndel1 in the adult mammalian central nervous system. Neuroscience 2014, 271:119-136.
93. Piggins H.D. Schizophrenia: zooming in on a gene. Nature 2011, 471:455-456.
94. Pulver A.E., Liang K.Y., Brown C.H., Wolyniec P., McGrath J., Adler L., Tam D., Carpenter W.T., Childs B. Risk factors in schizophrenia. Season of birth, gender, and familial risk. Br. J. Psychiatry 1992, 160:65-71.
95. Pulver A.E., Karayiorgou M., Wolyniec P.S., Lasseter V.K., Kasch L., Nestadt G., Antonarakis S., Housman D., Kazazian H.H., Meyers D., et al. Sequential strategy to identify a susceptibility gene for schizophrenia: report of potential linkage on chromosome 22q12-q13.1: Part 1. Am. J. Med. Genet. 1994, 54:36-43.
96. Purcell A.E., Jeon O.H., Zimmerman A.W., Blue M.E., Pevsner J. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology 2001, 57:1618-1628.
97. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81:559-575.
98. Purcell S.M., Moran J.L., Fromer M., Ruderfer D., Solovieff N., Roussos P., O'Dushlaine C., Chambert K., Bergen S.E., Kahler A., Duncan L., Stahl E., Genovese G., Fernandez E., Collins M.O., Komiyama N.H., Choudhary J.S., Magnusson P.K., Banks E., Shakir K., Garimella K., Fennell T., DePristo M., Grant S.G., Haggarty S.J., Gabriel S., Scolnick E.M., Lander E.S., Hultman C.M., Sullivan P.F., McCarroll S.A., Sklar P. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 2014, 506:185-190.
99. Ramocki M.B., Bartnik M., Szafranski P., Kolodziejska K.E., Xia Z., Bravo J., Miller G.S., Rodriguez D.L., Williams C.A., Bader P.I., Szczepanik E., Mazurczak T., Antczak-Marach D., Coldwell J.G., Akman C.I., McAlmon K., Cohen M.P., McGrath J., Roeder E., Mueller J., Kang S.H., Bacino C.A., Patel A., Bocian E., Shaw C.A., Cheung S.W., Mazurczak T., Stankiewicz P. Recurrent distal 7q11.23 deletion including HIP1 and YWHAG identified in patients with intellectual disabilities, epilepsy, and neurobehavioral problems. Am. J. Hum. Genet. 2010, 87:857-865.
100. Rees E., Walters J.T., Georgieva L., Isles A.R., Chambert K.D., Richards A.L., Mahoney-Davies G., Legge S.E., Moran J.L., McCarroll S.A., O'Donovan M.C., Owen M.J., Kirov G. Analysis of copy number variations at 15 schizophrenia-associated loci. Br. J. Psychiatry 2014, 204:108-114.
101. Rees E., Walters J.T.R., Chambert K.D., O'Dushlaine C., Szatkiewicz J., Richards A.L., Georgieva L., Mahoney-Davies G., Legge S.E., Moran J.L., Genovese G., Levinson D., Morris D.W., Cormican P., Kendler K.S., O'Neill F.A., Riley B., Gill M., Corvin A., C.Wellcome Trust Case Control, Sklar P., Hultman C., Pato C., Pato M., Sullivan P.F., Gejman P.V., McCarroll S.A., O'Donovan M.C., Owen M.J., Kirov G. CNV analysis in a large schizophrenia sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1. Hum. Mol. Genet. 2014, 23:1669-1676.
102. Rees E., Kirov G., Sanders A., Walters J.T., Chambert K.D., Shi J., Szatkiewicz J., O'Dushlaine C., Richards A.L., Green E.K., Jones I., Davies G., Legge S.E., Moran J.L., Pato C., Pato M., Genovese G., Levinson D., Duan J., Moy W., Goring H.H., Morris D., Cormican P., Kendler K.S., O'Neill F.A., Riley B., Gill M., Corvin A., Craddock N., Sklar P., Hultman C., Sullivan P.F., Gejman P.V., McCarroll S.A., O'Donovan M.C., Owen M.J. Evidence that duplications of 22q11.2 protect against schizophrenia. Mol. Psychiatry 2014, 19:37-40.
103. Riley B., Thiselton D., Maher B.S., Bigdeli T., Wormley B., McMichael G.O., Fanous A.H., Vladimirov V., O'Neill F.A., Walsh D., Kendler K.S. Replication of association between schizophrenia and ZNF804A in the Irish Case-Control study of Schizophrenia sample. Mol. Psychiatry 2010, 15:29-37.
104. Ripke S., O'Dushlaine C., Chambert K., Moran J.L., Kahler A.K., Akterin S., Bergen S.E., Collins A.L., Crowley J.J., Fromer M., Kim Y., Lee S.H., Magnusson P.K., Sanchez N., Stahl E.A., Williams S., Wray N.R., Xia K., Bettella F., Borglum A.D., Bulik-Sullivan B.K., Cormican P., Craddock N., de Leeuw C., Durmishi N., Gill M., Golimbet V., Hamshere M.L., Holmans P., Hougaard D.M., Kendler K.S., Lin K., Morris D.W., Mors O., Mortensen P.B., Neale B.M., O'Neill F.A., Owen M.J., Milovancevic M.P., Posthuma D., Powell J., Richards A.L., Riley B.P., Ruderfer D., Rujescu D., Sigurdsson E., Silagadze T., Smit A.B., Stefansson H., Steinberg S., Suvisaari J., Tosato S., Verhage M., Walters J.T., C.Multicenter Genetic Studies of Schizophrenia, Levinson D.F., Gejman P.V., Kendler K.S., Laurent C., Mowry B.J., O'Donovan M.C., Owen M.J., Pulver A.E., Riley B.P., Schwab S.G., Wildenauer D.B., Dudbridge F., Holmans P., Shi J., Albus M., Alexander M., Campion D., Cohen D., Dikeos D., Duan J., Eichhammer P., Godard S., Hansen M., Lerer F.B., Liang K.Y., Maier W., Mallet J., Nertney D.A., Nestadt G., Norton N., O'Neill F.A., Papadimitriou G.N., Ribble R., Sanders A.R., Silverman J.M., Walsh D., Williams N.M., Wormley B., C.Psychosis Endophenotypes International, Arranz M.J., Bakker S., Bender S., Bramon E., Collier D., Crespo-Facorro B., Hall J., Iyegbe C., Jablensky A., Kahn R.S., Kalaydjieva L., Lawrie S., Lewis C.M., Lin K., Linszen D.H., Mata I., McIntosh A., Murray R.M., Ophoff R.A., Powell J., Rujescu D., Van Os J., Walshe M., Weisbrod M., Wiersma D., C.Wellcome Trust Case Control, Donnelly P., Barroso I., Blackwell J.M., Bramon E., Brown M.A., Casas J.P., Corvin A.P., Deloukas P., Duncanson A., Jankowski J., Markus H.S., Mathew C.G., Palmer C.N., Plomin R., Rautanen A., Sawcer S.J., Trembath R.C., Viswanathan A.C., Wood N.W., Spencer C.C., Band G., Bellenguez C., Freeman C., Hellenthal G., Giannoulatou E., Pirinen M., Pearson R.D., Strange A., Su Z., Vukcevic D., Donnelly P., Langford C., Hunt S.E., Edkins S., Gwilliam R., Blackburn H., Bumpstead S.J., Dronov S., Gillman M., Gray E., Hammond N., Jayakumar A., McCann O.T., Liddle J., Potter S.C., Ravindrarajah R., Ricketts M., Tashakkori-Ghanbaria A., Waller M.J., Weston P., Widaa S., Whittaker P., Barroso I., Deloukas P., Mathew C.G., Blackwell J.M., Brown M.A., Corvin A.P., McCarthy M.I., Spencer C.C., Bramon E., Corvin A.P., O'Donovan M.C., Stefansson K., Scolnick E., Purcell S., McCarroll S.A., Sklar P., Hultman C.M., Sullivan P.F. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat. Genet. 2013, 45:1150-1159.
105. Rujescu D., Ingason A., Cichon S., Pietiläinen O.P.H., Barnes M.R., Toulopoulou T., Picchioni M., Vassos E., Ettinger U., Bramon E., Murray R., Ruggeri M., Tosato S., Bonetto C., Steinberg S., Sigurdsson E., Sigmundsson T., Petursson H., Gylfason A., Olason P.I., Hardarsson G., Jonsdottir G.A., Gustafsson O., Fossdal R., Giegling I., Möller H.-J., Hartmann A.M., Hoffmann P., Crombie C., Fraser G., Walker N., Lonnqvist J., Suvisaari J., Tuulio-Henriksson A., Djurovic S., Melle I., Andreassen O.A., Hansen T., Werge T., Kiemeney L.A., Franke B., Veltman J., Buizer-Voskamp J.E., Investigators G., Sabatti C., Ophoff R.A., Rietschel M., Nöthen M.M., Stefansson K., Peltonen L., Clair D.S., Stefansson H., Collier D.A. Disruption of the neurexin 1 gene is associated with schizophrenia. Hum. Mol. Genet. 2009, 18:988-996.
106. Said S.I., Berisha H.I., Pakbaz H. Excitotoxicity in the lung: N-methyl-D-aspartate-induced, nitric oxide-dependent, pulmonary edema is attenuated by vasoactive intestinal peptide and by inhibitors of poly(ADP-ribose) polymerase. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:4688-4692.
107. Sanders S.J., Ercan-Sencicek A.G., Hus V., Luo R., Murtha M.T., Moreno-De-Luca D., Chu S.H., Moreau M.P., Gupta A.R., Thomson S.A., Mason C.E., Bilguvar K., Celestino-Soper P.B., Choi M., Crawford E.L., Davis L., Wright N.R., Dhodapkar R.M., DiCola M., DiLullo N.M., Fernandez T.V., Fielding-Singh V., Fishman D.O., Frahm S., Garagaloyan R., Goh G.S., Kammela S., Klei L., Lowe J.K., Lund S.C., McGrew A.D., Meyer K.A., Moffat W.J., Murdoch J.D., O'Roak B.J., Ober G.T., Pottenger R.S., Raubeson M.J., Song Y., Wang Q., Yaspan B.L., Yu T.W., Yurkiewicz I.R., Beaudet A.L., Cantor R.M., Curland M., Grice D.E., Gunel M., Lifton R.P., Mane S.M., Martin D.M., Shaw C.A., Sheldon M., Tischfield J.A., Walsh C.A., Morrow E.M., Ledbetter D.H., Fombonne E., Lord C., Martin C.L., Brooks A.I., Sutcliffe J.S., Cook E.H., Geschwind D., Roeder K., Devlin B., State M.W. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 2011, 70:863-885.
108. Sanders S.J., Murtha M.T., Gupta A.R., Murdoch J.D., Raubeson M.J., Willsey A.J., Ercan-Sencicek A.G., DiLullo N.M., Parikshak N.N., Stein J.L., Walker M.F., Ober G.T., Teran N.A., Song Y., El-Fishawy P., Murtha R.C., Choi M., Overton J.D., Bjornson R.D., Carriero N.J., Meyer K.A., Bilguvar K., Mane S.M., Sestan N., Lifton R.P., Gunel M., Roeder K., Geschwind D.H., Devlin B., State M.W. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012, 485:237-241.
109. Sebat J., Levy D.L., McCarthy S.E. Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. Trends Genet. 2009, 25:528-535.
110. Shepherd J.D., Bear M.F. New views of Arc, a master regulator of synaptic plasticity. Nat. Neurosci. 2011, 14:279-284.
111. Shetty A.C., Athri P., Mondal K., Horner V.L., Steinberg K.M., Patel V., Caspary T., Cutler D.J., Zwick M.E. SeqAnt: a web service to rapidly identify and annotate DNA sequence variations. BMC Bioinform. 2010, 11:471.
112. Shi J., Levinson D.F., Duan J., Sanders A.R., Zheng Y., Pe'er I., Dudbridge F., Holmans P.A., Whittemore A.S., Mowry B.J., Olincy A., Amin F., Cloninger C.R., Silverman J.M., Buccola N.G., Byerley W.F., Black D.W., Crowe R.R., Oksenberg J.R., Mirel D.B., Kendler K.S., Freedman R., Gejman P.V. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009, 460:753-757.
113. Shimizu E., Tang Y.P., Rampon C., Tsien J.Z. NMDA receptor-dependent synaptic reinforcement as a crucial process for memory consolidation. Science 2000, 290:1170-1174.
114. Splawski I., Timothy K.W., Sharpe L.M., Decher N., Kumar P., Bloise R., Napolitano C., Schwartz P.J., Joseph R.M., Condouris K., Tager-Flusberg H., Priori S.G., Sanguinetti M.C., Keating M.T. CaV1.2 calcium channel dysfunction causes a multisystem disorder including Arrhythmia and autism. Cell 2004, 119:19-31.
115. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S., Ivarsson O., Chou T.T., Hjaltason O., Birgisdottir B., Jonsson H., Gudnadottir V.G., Gudmundsdottir E., Bjornsson A., Ingvarsson B., Ingason A., Sigfusson S., Hardardottir H., Harvey R.P., Lai D., Zhou M., Brunner D., Mutel V., Gonzalo A., Lemke G., Sainz J., Johannesson G., Andresson T., Gudbjartsson D., Manolescu A., Frigge M.L., Gurney M.E., Kong A., Gulcher J.R., Petursson H., Stefansson K. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 2002, 71:877-892.
116. Stefansson H., Rujescu D., Cichon S., Pietilainen O.P., Ingason A., Steinberg S., Fossdal R., Sigurdsson E., Sigmundsson T., Buizer-Voskamp J.E., Hansen T., Jakobsen K.D., Muglia P., Francks C., Matthews P.M., Gylfason A., Halldorsson B.V., Gudbjartsson D., Thorgeirsson T.E., Sigurdsson A., Jonasdottir A., Jonasdottir A., Bjornsson A., Mattiasdottir S., Blondal T., Haraldsson M., Magnusdottir B.B., Giegling I., Moller H.J., Hartmann A., Shianna K.V., Ge D., Need A.C., Crombie C., Fraser G., Walker N., Lonnqvist J., Suvisaari J., Tuulio-Henriksson A., Paunio T., Toulopoulou T., Bramon E., Di Forti M., Murray R., Ruggeri M., Vassos E., Tosato S., Walshe M., Li T., Vasilescu C., Muhleisen T.W., Wang A.G., Ullum H., Djurovic S., Melle I., Olesen J., Kiemeney L.A., Franke B., Group, Sabatti C., Freimer N.B., Gulcher J.R., Thorsteinsdottir U., Kong A., Andreassen O.A., Ophoff R.A., Georgi A., Rietschel M., Werge T., Petursson H., Goldstein D.B., Nothen M.M., Peltonen L., Collier D.A., St Clair D., Stefansson K. Large recurrent microdeletions associated with schizophrenia. Nature 2008, 455:232-236.
117. Stefansson H., Ophoff R.A., Steinberg S., Andreassen O.A., Cichon S., Rujescu D., Werge T., Pietiläinen O.P.H., Mors O., Mortensen P.B., Sigurdsson E., Gustafsson O., Nyegaard M., Tuulio-Henriksson A., Ingason A., Hansen T., Suvisaari J., Lonnqvist J., Paunio T., Børglum A.D., Hartmann A., Fink-Jensen A., Nordentoft M., Hougaard D., Norgaard-Pedersen B., Böttcher Y., Olesen J., Breuer R., Möller H.-J., Giegling I., Rasmussen H.B., Timm S., Mattheisen M., Bitter I., Réthelyi J.M., Magnusdottir B.B., Sigmundsson T., Olason P., Masson G., Gulcher J.R., Haraldsson M., Fossdal R., Thorgeirsson T.E., Thorsteinsdottir U., Ruggeri M., Tosato S., Franke B., Strengman E., Kiemeney L.A., Group, Melle I., Djurovic S., Abramova L., Kaleda V., Sanjuan J., de Frutos R., Bramon E., Vassos E., Fraser G., Ettinger U., Picchioni M., Walker N., Toulopoulou T., Need A.C., Ge D., Yoon J.L., Shianna K.V., Freimer N.B., Cantor R.M., Murray R., Kong A., Golimbet V., Carracedo A., Arango C., Costas J., Jönsson E.G., Terenius L., Agartz I., Petursson H., Nöthen M.M., Rietschel M., Matthews P.M., Muglia P., Peltonen L., St Clair D., Goldstein D.B., Stefansson K., Collier D.A. Common variants conferring risk of schizophrenia. Nature 2009, 460:744-747.
118. Steward O., Wallace C.S., Lyford G.L., Worley P.F. Synaptic activation causes the mRNA for the IEG Arc to localize selectively near activated postsynaptic sites on dendrites. Neuron 1998, 21:741-751.
119. Stewart L.R., Hall A.L., Kang S.H., Shaw C.A., Beaudet A.L. High frequency of known copy number abnormalities and maternal duplication 15q11-q13 in patients with combined schizophrenia and epilepsy. BMC Med. Genet. 2011, 12:154.
120. Sullivan P.F., Lin D., Tzeng J.Y., van den Oord E., Perkins D., Stroup T.S., Wagner M., Lee S., Wright F.A., Zou F., Liu W., Downing A.M., Lieberman J., Close S.L. Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol. Psychiatry 2008, 13:570-584.
121. Sullivan P.F., Daly M.J., O'Donovan M. Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat. Rev. Genet. 2012, 13:537-551.
122. Szatkiewicz J.P., O'Dushlaine C., Chen G., Chambert K., Moran J.L., Neale B.M., Fromer M., Ruderfer D., Akterin S., Bergen S.E., Kahler A., Magnusson P.K., Kim Y., Crowley J.J., Rees E., Kirov G., O'Donovan M.C., Owen M.J., Walters J., Scolnick E., Sklar P., Purcell S., Hultman C.M., McCarroll S.A., Sullivan P.F. Copy number variation in schizophrenia in Sweden. Mol. Psychiatry 2014, 19:762-773.
123. Tandon R., Keshavan M.S., Nasrallah H.A. Schizophrenia, "Just the Facts" what we know in 2008. 2. Epidemiology and etiology. Schizoph. Res. 2008, 102:1-18.
124. Tandon R., Gaebel W., Barch D.M., Bustillo J., Gur R.E., Heckers S., Malaspina D., Owen M.J., Schultz S., Tsuang M., Van Os J., Carpenter W. Definition and description of schizophrenia in the DSM-5. Schizoph. Res. 2013, 150:3-10.
125. Tassabehji M. Williams-Beuren syndrome: a challenge for genotype-phenotype correlations. Hum. Mol. Genet. 2003, 12(Spec No 2):R229-R237.
126. Torrey E.F., Torrey B.B., Peterson M.R. Seasonality of schizophrenic births in the United States. Arch. Gen. Psychiatry 1977, 34:1065-1070.
127. Ullmann R., Turner G., Kirchhoff M., Chen W., Tonge B., Rosenberg C., Field M., Vianna-Morgante A.M., Christie L., Krepischi-Santos A.C., Banna L., Brereton A.V., Hill A., Bisgaard A.-M., Müller I., Hultschig C., Erdogan F., Wieczorek G., Ropers H.H. Array CGH identifies reciprocal 16p13.1 duplications and deletions that predispose to autism and/or mental retardation. Hum. Mutat. 2007, 28:674-682.
128. Vacic V., McCarthy S., Malhotra D., Murray F., Chou H.H., Peoples A., Makarov V., Yoon S., Bhandari A., Corominas R., Iakoucheva L.M., Krastoshevsky O., Krause V., Larach-Walters V., Welsh D.K., Craig D., Kelsoe J.R., Gershon E.S., Leal S.M., Dell Aquila M., Morris D.W., Gill M., Corvin A., Insel P.A., McClellan J., King M.C., Karayiorgou M., Levy D.L., DeLisi L.E., Sebat J. Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia. Nature 2011, 471:499-503.
129. Van der Aa N., Rooms L., Vandeweyer G., van den Ende J., Reyniers E., Fichera M., Romano C., Delle Chiaie B., Mortier G., Menten B., Destree A., Maystadt I., Mannik K., Kurg A., Reimand T., McMullan D., Oley C., Brueton L., Bongers E.M., van Bon B.W., Pfund R., Jacquemont S., Ferrarini A., Martinet D., Schrander-Stumpel C., Stegmann A.P., Frints S.G., de Vries B.B., Ceulemans B., Kooy R.F. Fourteen new cases contribute to the characterization of the 7q11.23 microduplication syndrome. Eur. J. Med. Genet. 2009, 52:94-100.
130. Verkhratsky A., Kirchhoff F. NMDA receptors in glia. Neuroscientist 2007, 13:28-37.
131. Vorstman J.A., Breetvelt E.J., Duijff S.N., Eliez S., Schneider M., Jalbrzikowski M., Armando M., Vicari S., Shashi V., Hooper S.R., Chow E.W., Fung W.L., Butcher N.J., Young D.A., McDonald-McGinn D.M., Vogels A., van Amelsvoort T., Gothelf D., Weinberger R., Weizman A., Klaassen P.W., Koops S., Kates W.R., Antshel K.M., Simon T.J., Ousley O.Y., Swillen A., Gur R.E., Bearden C.E., Kahn R.S., Bassett A.S., B.International Consortium on, S.Behavior in 22q11.2 Deletion Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome. JAMA Psychiatry 2015, 72:377-385.
132. Vrajova M., Stastny F., Horacek J., Lochman J., Sery O., Pekova S., Klaschka J., Hoschl C. Expression of the hippocampal NMDA receptor GluN1 subunit and its splicing isoforms in schizophrenia: postmortem study. Neurochem. Res. 2010, 35:994-1002.
133. Walsh T., McClellan J.M., McCarthy S.E., Addington A.M., Pierce S.B., Cooper G.M., Nord A.S., Kusenda M., Malhotra D., Bhandari A., Stray S.M., Rippey C.F., Roccanova P., Makarov V., Lakshmi B., Findling R.L., Sikich L., Stromberg T., Merriman B., Gogtay N., Butler P., Eckstrand K., Noory L., Gochman P., Long R., Chen Z., Davis S., Baker C., Eichler E.E., Meltzer P.S., Nelson S.F., Singleton A.B., Lee M.K., Rapoport J.L., King M.C., Sebat J. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008, 320:539-543.
134. Weickert C.S., Fung S.J., Catts V.S., Schofield P.R., Allen K.M., Moore L.T., Newell K.A., Pellen D., Huang X.F., Catts S.V., Weickert T.W. Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia. Mol. Psychiatry 2013, 18:1185-1192.
135. Weiss L.A., Escayg A., Kearney J.A., Trudeau M., MacDonald B.T., Mori M., Reichert J., Buxbaum J.D., Meisler M.H. Sodium channels SCN1A, SCN2A and SCN3A in familial autism. Mol. Psychiatry 2003, 8:186-194.
136. Weiss L.A., Shen Y., Korn J.M., Arking D.E., Miller D.T., Fossdal R., Saemundsen E., Stefansson H., Ferreira M.A.R., Green T., Platt O.S., Ruderfer D.M., Walsh C.A., Altshuler D., Chakravarti A., Tanzi R.E., Stefansson K., Santangelo S.L., Gusella J.F., Sklar P., Wu B.-L., Daly M.J. Association between microdeletion and microduplication at 16p11.2 and Autism. N. Engl. J. Med. 2008, 358:667-675.
137. Wu M.C., Lee S., Cai T., Li Y., Boehnke M., Lin X. Rare-variant association testing for sequencing data with the sequence kernel association test. Am. J. Hum. Genet. 2011, 89:82-93.
138. Yuan J., Jin C., Sha W., Zhou Z., Zhang F., Wang M., Wang J., Li J., Feng X., Yu S., Wang J. A competitive PCR assay confirms the association of a copy number variation in the VIPR2 gene with schizophrenia in Han Chinese. Schizoph. Res. 2014, 156:66-70.